Who is sponsoring NCT01564680?

NCT01564680 is sponsored by Imam Abdulrahman Bin Faisal University.

What condition does NCT01564680 study?

NCT01564680 studies Postoperative Pain.

What drugs are being tested in NCT01564680?

Interventions: placebo, Paracetamol, Lornoxicam.

What is the status of NCT01564680?

NCT01564680 is currently COMPLETED.

Last reviewed 2012-03-27 · How we verify

Intravenous Lornoxicam is More Effective Than Paracetamol as a Supplemental Analgesic After Lower Abdominal Surgery; A Randomized Controlled Trial

NCT01564680 Phase 4 COMPLETED

Background: The aim of this prospective, randomized, double-blind study is to determine the most effective supplemental analgesic, paracetamol or lornoxicam for postoperative pain relief after lower abdominal surgery. Methods: Sixty patients scheduled for lower abdominal surgery under general anesthesia were randomly allocated to receive either isotonic saline (Control group), intravenous paracetamol 1 g every 6 h (Paracetamol group) or lornoxicam 16 mg then 8 mg after 12 h (Lornoxicam group). Additionally pain was treated postoperatively using morphine patient-controlled analgesia. Postoperative pain scores measured by the verbal pain score (VPS), morphine consumption and the incidence of side effects were measured at 1, 2, 4, 8, 12 and 24 hours postoperatively.

Details

Lead sponsor	Imam Abdulrahman Bin Faisal University
Phase	Phase 4
Status	COMPLETED
Enrolment	60
Start date	2009-03
Completion	2011-03

Conditions

Postoperative Pain

Interventions

placebo
Paracetamol
Lornoxicam

Primary outcomes

Postoperative pain — 24 hours
Postoperative pain scores measured by the verbal pain score (VPS)1, 2, 4, 8, 12 and 24 hours postoperatively.

Countries

Saudi Arabia